Polyclonal Rabbit anti‑Human CXCL11 Antibody (Cy3, aa22‑94, WB) LS‑C701967
Polyclonal Rabbit anti‑Human CXCL11 Antibody (Cy3, aa22‑94, WB) LS‑C701967
Antibody:
CXCL11 Rabbit anti-Human Polyclonal (aa22-94) (Cy3) Antibody
Overview
Antibody:
CXCL11 Rabbit anti-Human Polyclonal (aa22-94) (Cy3) Antibody
Specifications
Description
CXCL11 antibody LS-C701967 is a Cy3-conjugated rabbit polyclonal antibody to human CXCL11 (aa22-94). Validated for WB.
Target
Human CXCL11
Synonyms
CXCL11 | Beta-R1 | Chemokine h174 | Chemokine ip-9 | Chemokine itac | H174 | I-TAC | IP9 | ITAC | IP-9 | SCYB11 | Small inducible cytokine B11 | B-R1 | C-X-C motif chemokine 11 | SCYB9B | Small-inducible cytokine B11
Reactivity
Human
(tested or 100% immunogen sequence identity)
Conjugations
Cy3.
Also available
Unconjugated or conjugated with
Biotin,
FITC,
HRP,
APC,
PE,
APC, Cy7.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Immunogen
Recombinant ITaC (Phe22-Phe94) expressed in E. coli.
Specificity
The antibody is a rabbit polyclonal antibody raised against ITaC.
Applications
- Western blot
- Applications tested for the base form of this product only
Presentation
PBS, pH 7.4, 0.02% Sodium Azide, 50% Glycerol
Storage
Avoid repeated freeze/thaw cycles. Store at 4°C for frequent use. Aliquot and store at -20°C for 12 months.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot, ELISA
Species:
Human
Applications:
IHC, IHC - Paraffin, Immunoprecipitation, ELISA
Species:
Human
Applications:
Western blot
Species:
Human
Applications:
Western blot, ELISA
Species:
Mouse, Human
Applications:
ELISA
Species:
Mouse, Human
Applications:
IHC, Western blot, ELISA
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 2/3/2025